Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| APEC14B1 | COG | The Project: Everychild Protocol: A Registry; Eligibility Screening; Biology and Outcome Study | Pediatric CIRB | Available to Open | |
| APEC1621-MASTER | COG | NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Study | Pediatric CIRB | Available to Open | |
| ARAR0331 | COG | Treatment of Childhood Nasopharyngeal Carcinoma with Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study | Pediatric CIRB | Completed | |
| ARAR0332 | COG | Treatment of Adrenocortical Tumors with Surgery plus Lymph Node Dissection and Multiagent Chemotherapy: A Groupwide Phase III Study | Pediatric CIRB | Available to Open | |
| ARAR2221 | COG | Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC) | Pediatric CIRB | Available to Open | |
| ARAR2331 | COG | Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB) | Pediatric CIRB | Available to Open | |
| AREN0321 | COG | Treatment of High Risk Renal Tumors: A Groupwide Phase II Study | Pediatric CIRB | Completed | |
| AREN03B2 | COG | Renal Tumors Classification; Biology; and Banking Study | Pediatric CIRB | Available to Open | |
| AREN0532 | COG | Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor: A Groupwide Phase III Study | Pediatric CIRB | Available to Open | |
| AREN0533 | COG | Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors: A Groupwide Phase III Study | Pediatric CIRB | Available to Open |